Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2016 06:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Exhibit at 14th International Cord Blood Symposium

RANCHO CORDOVA, Calif., June 08, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will be...
June 06, 2016 06:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the LD Micro Invitational Conference

RANCHO CORDOVA, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Mr. Michael Bruch, the...
June 01, 2016 11:15 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Submits Investigational Device Exemption Supplement for SurgWerks™ CLI Pivotal Trial

RANCHO CORDOVA, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has...
May 24, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Exhibit at the 2016 International Society for Cellular Therapy Annual Meeting

RANCHO CORDOVA, Calif., May 24, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will be...
May 20, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Review Recent Corporate Milestones at the Marcum MicroCap Conference

RANCHO CORDOVA, Calif., May 20, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company’s...
May 19, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Publication of a Case Report on Use of Its Technology for Treatment of Acute Myocardial Infarction

Data highlights promising results obtained from the AMIRST pilot study. RANCHO CORDOVA, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based...
May 12, 2016 16:37 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results and Provides Business Update

RANCHO CORDOVA, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today reported financial results for the third...
May 11, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Reports Data From Six CLI Compassionate Use Patients Treated With SurgWerks™ Procedures at Fortis Escorts Heart Institute in New Delhi

RANCHO CORDOVA, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced the results of six late-stage...
May 09, 2016 18:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Report Third Quarter Fiscal 2016 Results on May 12, 2016

RANCHO CORDOVA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that it will report...
March 31, 2016 06:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics To Present A Poster At The 2016 Annual Meeting Of The European Society For Blood And Bone Marrow Transplantation

RANCHO CORDOVA, Calif., March 31, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company will...